Involvement of cathepsin B in Alzheimer's disease (AD)-like pathologies following chronic systemic treatment with lipopolyssacharide from Porphyromonas gingivalis

被引：0
作者：
Wu, Zhou [1 ]
Ni, Junjun [1 ]
Nakanishi, Hiroshi [1 ]
机构：
[1] Kyushu Univ, Fac Dent Sci, Dept Aging Sci & Pharmacol, Fukuoka, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2016年 / 130卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
3-O-72
引用
收藏
页码：S128 / S128
页数：1
相关论文
共 50 条
  • [41] Chronic Sleep Deprivation Exacerbates Learning-Memory Disability and Alzheimer's Disease-Like Pathologies in AβPPswe/PS1ΔE9 Mice
    Qiu, Hongyan
    Zhong, Rujia
    Liu, Hui
    Zhang, Feng
    Li, Song
    Le, Weidong
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 50 (03) : 669 - 685
  • [42] Differential effects of chronic stress on anxiety-like behavior and contextual fear conditioning in the TgF344-AD rat model of Alzheimer's disease
    Pentkowski, Nathan S.
    Bouquin, Samuel J.
    Maestas-Olguin, Carlos R.
    Villasenor, Zachary M.
    Clark, Benjamin J.
    BEHAVIOURAL BRAIN RESEARCH, 2022, 418
  • [43] Protein profiling of CD11b+ CNS myeloid cells from aged APPSWE/PS1DE9 and wildtype mice points to the involvement of cathepsin Z in Alzheimer's disease
    Thygesen, C.
    Hemdrup, A. L.
    Ilkjaer, L.
    Kempf, S. S.
    von Linstow, C. U.
    Babcock, A. A.
    Darvesh, S.
    Larsen, M. R.
    Finsen, B.
    GLIA, 2019, 67 : E616 - E617
  • [44] Disruptions to anxiety behavior following chronic ethanol consumption are sex-specific in the transgenic TGF344-ad Alzheimer's disease rat model
    Marsland, P.
    Held, A.
    Savage, L.
    Deak, T.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 : 275 - 276
  • [45] Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease
    Cline, Erika N.
    Antwi-Berko, Daniel
    Sundell, Karen
    Johnson, Elizabeth
    Hyland, Maddelyn
    Zhang, Hao
    Vanderstichele, Hugo
    Kaplow, June
    Dean, Robert A.
    Stoops, Erik
    Vanmechelen, Eugeen
    Koel-Simmelink, Marleen J. A.
    Teunissen, Charlotte E.
    Sethuraman, Gopalan
    Feaster, Todd
    Siemers, Eric
    Jerecic, Jasna
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2025, 12 (04): : 100082
  • [46] Neuroprotective effects of polysaccharide from Sparassis crispa on Alzheimer's disease-like mice: Involvement of microbiota-gut-brain axis
    Zhang, Wenyi
    Guo, Yahui
    Cheng, Yuliang
    Yao, Weirong
    Qian, He
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2023, 225 : 974 - 986
  • [47] Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer’s disease following chronic donepezil treatment
    T. Darreh-Shori
    L. Meurling
    T. Pettersson
    K. Hugosson
    E. Hellström-Lindahl
    N. Andreasen
    L. Minthon
    A. Nordberg
    Journal of Neural Transmission, 2006, 113 : 1791 - 1801
  • [48] Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment
    Darreh-Shori, T.
    Meurling, L.
    Pettersson, T.
    Hugosson, K.
    Hellstrom-Lindahl, E.
    Andreasen, N.
    Minthon, L.
    Nordberg, A.
    JOURNAL OF NEURAL TRANSMISSION, 2006, 113 (11) : 1791 - 1801
  • [49] Characterization of preclinical Alzheimer’s disease model: spontaneous type 2 diabetic cynomolgus monkeys with systemic pro-inflammation, positive biomarkers and developing AD-like pathology
    Xinxin Huang
    Shanshan Huang
    Fangyan Fu
    Junzhen Song
    Yuling Zhang
    Feng Yue
    Alzheimer's Research & Therapy, 16
  • [50] Characterization of preclinical Alzheimer's disease model: spontaneous type 2 diabetic cynomolgus monkeys with systemic pro-inflammation, positive biomarkers and developing AD-like pathology
    Huang, Xinxin
    Huang, Shanshan
    Fu, Fangyan
    Song, Junzhen
    Zhang, Yuling
    Yue, Feng
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
12345